Detection of mycobacterial CFP-10 (Rv3874) protein in tuberculosis patients by gold nanoparticle-based real-time immuno-PCR

Author:

Dahiya Bhawna1,Sharma Suman1,Khan Anish1ORCID,Kamra Ekta1,Mor Preeti1,Sheoran Abhishek2,Sreenivas Vishnubhatla3,Varma-Basil Mandira4,Gupta Krishna B5,Gupta Mahesh C6,Chaudhary Dhruva7,Mehta Promod K1

Affiliation:

1. Centre for Biotechnology, Maharshi Dayanand University (MDU), Rohtak 124001, Haryana, India

2. Department of Statistics, Ramanujan College, University of Delhi, New Delhi 110019, India

3. Department of Biostatistics, All India Institute of Medical Sciences, New Delhi 110029, India

4. Department of Microbiology, Vallabhbhai Patel (VP) Chest Institute, University of Delhi, Delhi 110007, India

5. Department of TB & Respiratory Medicine, University of Health Sciences (UHS), Rohtak 124001, Haryana, India

6. Department of Pharmacology, UHS, Rohtak 124001, Haryana, India

7. Pulmonary & Critical Care Medicine, UHS, Rohtak 124001, Haryana, India

Abstract

Aim: Timely and reliable diagnostic test for tuberculosis (TB) is immediately required. Attempts were made to improve the technology and diagnostic potential of real-time immuno-PCR (RT-I-PCR). Methods: We designed gold nanoparticle (GNP)-based RT-I-PCR (GNP-RT-I-PCR) assay for the detection of Mycobacterium tuberculosis CFP-10 (Rv3874) protein in clinical samples of TB patients. Results: A wide quantitative detection range of CFP-10 was found to be 0.5–5 × 104 pg/ml in bodily fluids of TB patients, which can evaluate the progression of disease. Moreover, sensitivities of 83.7 and 76.2% were observed in pulmonary (n = 49) and extrapulmonary TB (n = 42) patients, respectively, with specificities of 93.5–93.8% (n = 63). Conclusion: Conjugation of detection antibodies and oligonucleotides to functionalized GNPs of GNP-RT-I-PCR is relatively easier, compared with streptavidin-biotin/succinimidyl-4-( N-maleimidomethyl) cyclohexane-1-carboxylate system employed in RT-I-PCR. Our assay also showed better diagnostic performance than RT-I-PCR, which may provide a viable platform for the development of an efficient TB diagnostic test.

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3